Beckersbehavioralhealth

Published October 5, 2026

FDA weighs framework for ibogaine trials - Becker's Behavioral Health

Read the full story at Beckersbehavioralhealth

psychedelic medicine research. The FDA finalized industry guidance for psychedelic drug clinical investigations in July 2026 and has allowed an.